ID   DAPK1_HUMAN             Reviewed;        1430 AA.
AC   P53355; B7ZLD2; Q14CQ7; Q1W5W0; Q68CP8; Q9BTL8;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   23-SEP-2008, sequence version 5.
DT   02-NOV-2010, entry version 119.
DE   RecName: Full=Death-associated protein kinase 1;
DE            Short=DAP kinase 1;
DE            EC=2.7.11.1;
GN   Name=DAPK1; Synonyms=DAPK;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), FUNCTION, INDUCTION, AND
RP   MUTAGENESIS OF LYS-42.
RX   MEDLINE=95129831; PubMed=7828849;
RA   Deiss L.P., Feinstein E., Berissi H., Cohen O., Kimchi A.;
RT   "Identification of a novel serine/threonine kinase and a novel 15-kD
RT   protein as potential mediators of the gamma interferon-induced cell
RT   death.";
RL   Genes Dev. 9:15-30(1995).
RN   [2]
RP   SEQUENCE REVISION TO 164-171.
RA   Feinstein E.;
RL   Submitted (APR-1997) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Amygdala;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS LEU-591; MET-622;
RP   SER-1346 AND VAL-1405.
RG   NIEHS SNPs program;
RL   Submitted (MAR-2006) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANT SER-1346.
RX   PubMed=15164053; DOI=10.1038/nature02465;
RA   Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E.,
RA   Howe K.L., Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Ashwell R.I.S.,
RA   Babbage A.K., Babbage S., Bagguley C.L., Bailey J., Banerjee R.,
RA   Barker D.J., Barlow K.F., Bates K., Beasley H., Beasley O., Bird C.P.,
RA   Bray-Allen S., Brown A.J., Brown J.Y., Burford D., Burrill W.,
RA   Burton J., Carder C., Carter N.P., Chapman J.C., Chen Y., Clarke G.,
RA   Clark S.Y., Clee C.M., Clegg S., Collier R.E., Corby N., Crosier M.,
RA   Cummings A.T., Davies J., Dhami P., Dunn M., Dutta I., Dyer L.W.,
RA   Earthrowl M.E., Faulkner L., Fleming C.J., Frankish A.,
RA   Frankland J.A., French L., Fricker D.G., Garner P., Garnett J.,
RA   Ghori J., Gilbert J.G.R., Glison C., Grafham D.V., Gribble S.,
RA   Griffiths C., Griffiths-Jones S., Grocock R., Guy J., Hall R.E.,
RA   Hammond S., Harley J.L., Harrison E.S.I., Hart E.A., Heath P.D.,
RA   Henderson C.D., Hopkins B.L., Howard P.J., Howden P.J., Huckle E.,
RA   Johnson C., Johnson D., Joy A.A., Kay M., Keenan S., Kershaw J.K.,
RA   Kimberley A.M., King A., Knights A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C., Lloyd D.M.,
RA   Lovell J., Martin S., Mashreghi-Mohammadi M., Matthews L., McLaren S.,
RA   McLay K.E., McMurray A., Milne S., Nickerson T., Nisbett J.,
RA   Nordsiek G., Pearce A.V., Peck A.I., Porter K.M., Pandian R.,
RA   Pelan S., Phillimore B., Povey S., Ramsey Y., Rand V., Scharfe M.,
RA   Sehra H.K., Shownkeen R., Sims S.K., Skuce C.D., Smith M.,
RA   Steward C.A., Swarbreck D., Sycamore N., Tester J., Thorpe A.,
RA   Tracey A., Tromans A., Thomas D.W., Wall M., Wallis J.M., West A.P.,
RA   Whitehead S.L., Willey D.L., Williams S.A., Wilming L., Wray P.W.,
RA   Young L., Ashurst J.L., Coulson A., Blocker H., Durbin R.M.,
RA   Sulston J.E., Hubbard T., Jackson M.J., Bentley D.R., Beck S.,
RA   Rogers J., Dunham I.;
RT   "DNA sequence and analysis of human chromosome 9.";
RL   Nature 429:369-374(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT
RP   SER-1346.
RC   TISSUE=Cerebellum;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1-363.
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   MEDLINE=20094983; PubMed=10629061;
RX   DOI=10.1128/MCB.20.3.1044-1054.2000;
RA   Inbal B., Shani G., Cohen O., Kissil J.L., Kimchi A.;
RT   "Death-associated protein kinase-related protein 1, a novel
RT   serine/threonine kinase involved in apoptosis.";
RL   Mol. Cell. Biol. 20:1044-1054(2000).
RN   [10]
RP   FUNCTION, ENZYME REGULATION, MUTAGENESIS OF LYS-42; SER-308 AND
RP   SER-313, AND PHOSPHORYLATION AT SER-308.
RX   PubMed=11579085; DOI=10.1074/jbc.M105133200;
RA   Shohat G., Spivak-Kroizman T., Cohen O., Bialik S., Shani G.,
RA   Berissi H., Eisenstein M., Kimchi A.;
RT   "The pro-apoptotic function of death-associated protein kinase is
RT   controlled by a unique inhibitory autophosphorylation-based
RT   mechanism.";
RL   J. Biol. Chem. 276:47460-47467(2001).
RN   [11]
RP   UBIQUITINATION, AND INTERACTION WITH KLHL20.
RX   PubMed=20389280; DOI=10.1038/emboj.2010.62;
RA   Lee Y.R., Yuan W.C., Ho H.C., Chen C.H., Shih H.M., Chen R.H.;
RT   "The Cullin 3 substrate adaptor KLHL20 mediates DAPK ubiquitination to
RT   control interferon responses.";
RL   EMBO J. 29:1748-1761(2010).
RN   [12]
RP   X-RAY CRYSTALLOGRAPHY (1.5 ANGSTROMS) OF 2-285 IN COMPLEX WITH ATP
RP   ANALOG AND DIVALENT METAL CATION.
RX   PubMed=11573098; DOI=10.1038/nsb1001-899;
RA   Tereshko V., Teplova M., Brunzelle J., Watterson D.M., Egli M.;
RT   "Crystal structures of the catalytic domain of human protein kinase
RT   associated with apoptosis and tumor suppression.";
RL   Nat. Struct. Biol. 8:899-907(2001).
RN   [13]
RP   X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS) OF 2-285 IN COMPLEX WITH
RP   SYNTHETIC INHIBITOR.
RX   PubMed=14505650; DOI=10.1016/S0960-894X(03)00733-9;
RA   Velentza A.V., Wainwright M.S., Zasadzki M., Mirzoeva S.,
RA   Schumacher A.M., Haiech J., Focia P.J., Egli M., Watterson D.M.;
RT   "An aminopyridazine-based inhibitor of a pro-apoptotic protein kinase
RT   attenuates hypoxia-ischemia induced acute brain injury.";
RL   Bioorg. Med. Chem. Lett. 13:3465-3470(2003).
RN   [14]
RP   X-RAY CRYSTALLOGRAPHY (2.40 ANGSTROMS) OF 1-278 IN COMPLEX WITH
RP   INHIBITORS.
RA   Ueda Y., Ogata H., Yamakawa A., Higuchi Y.;
RT   "Complex structure of kinase domain of DAP kinase with
RT   staurosporine.";
RL   Submitted (APR-2006) to the PDB data bank.
RN   [15]
RP   X-RAY CRYSTALLOGRAPHY (1.70 ANGSTROMS) OF 302-320 IN COMPLEX WITH
RP   CALMODULIN.
RA   Kursula P., Vahokoski J., Wilmanns M.;
RT   "Recognition of human death-associated protein kinases by
RT   calmodulin.";
RL   Submitted (JUL-2006) to the PDB data bank.
RN   [16]
RP   VARIANTS [LARGE SCALE ANALYSIS] ILE-416; SER-461; ALA-519; TYR-540;
RP   THR-941; TRP-977; ASN-978; CYS-993; GLU-994; GLN-1005; TYR-1007;
RP   PRO-1008; CYS-1010; ALA-1018; ILE-1272; SER-1346 AND VAL-1405.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Calcium/calmodulin-dependent serine/threonine kinase
CC       which acts as a positive regulator of apoptosis.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- COFACTOR: Magnesium.
CC   -!- ENZYME REGULATION: Negatively regulated by autophosphorylation on
CC       Ser-308.
CC   -!- SUBUNIT: Interacts with KLHL20.
CC   -!- INTERACTION:
CC       P27361:MAPK3; NbExp=3; IntAct=EBI-358616, EBI-73995;
CC       O75340:PDCD6; NbExp=3; IntAct=EBI-358616, EBI-352915;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm. Note=Colocalizes with the actin
CC       filament system.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P53355-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P53355-2; Sequence=VSP_035459, VSP_035460;
CC   -!- INDUCTION: Up-regulated following treatment with IFNG/IFN-gamma.
CC   -!- PTM: Ubiquitinated by the BCR(KLHL20) E3 ubiquitin ligase complex,
CC       leading to its degradation by the proteasome.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. CAMK
CC       Ser/Thr protein kinase family. DAP kinase subfamily.
CC   -!- SIMILARITY: Contains 10 ANK repeats.
CC   -!- SIMILARITY: Contains 1 death domain.
CC   -!- SIMILARITY: Contains 1 protein kinase domain.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=CAA53712.1; Type=Frameshift; Positions=462, 464;
CC   -!- WEB RESOURCE: Name=NIEHS-SNPs;
CC       URL="http://egp.gs.washington.edu/data/dapk1/";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X76104; CAA53712.1; ALT_FRAME; mRNA.
DR   EMBL; CR749834; CAH18690.1; -; mRNA.
DR   EMBL; DQ436495; ABD96827.1; -; Genomic_DNA.
DR   EMBL; AL160279; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL161787; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL591852; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471089; EAW62727.1; -; Genomic_DNA.
DR   EMBL; BC113660; AAI13661.1; -; mRNA.
DR   EMBL; BC143733; AAI43734.1; -; mRNA.
DR   EMBL; BT006935; AAP35581.1; ALT_TERM; mRNA.
DR   IPI; IPI00021250; -.
DR   IPI; IPI00909908; -.
DR   PIR; I37275; I37275.
DR   RefSeq; NP_004929.2; -.
DR   UniGene; Hs.380277; -.
DR   UniGene; Hs.693441; -.
DR   PDB; 1IG1; X-ray; 1.80 A; A=2-285.
DR   PDB; 1JKK; X-ray; 2.40 A; A=2-285.
DR   PDB; 1JKL; X-ray; 1.62 A; A=2-285.
DR   PDB; 1JKS; X-ray; 1.50 A; A=2-285.
DR   PDB; 1JKT; X-ray; 3.50 A; A/B=2-285.
DR   PDB; 1P4F; X-ray; 1.90 A; A=2-285.
DR   PDB; 1WVW; X-ray; 2.40 A; A=1-278.
DR   PDB; 1WVX; X-ray; 2.60 A; A=1-278.
DR   PDB; 1WVY; X-ray; 2.80 A; A=1-278.
DR   PDB; 1YR5; X-ray; 1.70 A; B=302-320.
DR   PDB; 2W4J; X-ray; 1.30 A; A=1-277.
DR   PDB; 2W4K; X-ray; 1.90 A; A=1-302.
DR   PDB; 2X0G; X-ray; 2.20 A; A=1-334.
DR   PDB; 3DFC; X-ray; 1.90 A; B=1-285.
DR   PDB; 3DGK; X-ray; 1.70 A; A=1-285.
DR   PDB; 3EH9; X-ray; 1.70 A; A=2-285.
DR   PDB; 3EHA; X-ray; 1.60 A; A=2-285.
DR   PDB; 3F5G; X-ray; 1.85 A; A=2-285.
DR   PDB; 3F5U; X-ray; 2.00 A; A=1-285.
DR   PDB; 3GU4; X-ray; 1.35 A; A=1-285.
DR   PDB; 3GU5; X-ray; 1.65 A; A=1-285.
DR   PDB; 3GU6; X-ray; 1.49 A; A=1-285.
DR   PDB; 3GU7; X-ray; 1.90 A; A=1-285.
DR   PDB; 3GU8; X-ray; 1.60 A; A=1-285.
DR   PDB; 3GUB; X-ray; 1.71 A; A=1-285.
DR   PDBsum; 1IG1; -.
DR   PDBsum; 1JKK; -.
DR   PDBsum; 1JKL; -.
DR   PDBsum; 1JKS; -.
DR   PDBsum; 1JKT; -.
DR   PDBsum; 1P4F; -.
DR   PDBsum; 1WVW; -.
DR   PDBsum; 1WVX; -.
DR   PDBsum; 1WVY; -.
DR   PDBsum; 1YR5; -.
DR   PDBsum; 2W4J; -.
DR   PDBsum; 2W4K; -.
DR   PDBsum; 2X0G; -.
DR   PDBsum; 3DFC; -.
DR   PDBsum; 3DGK; -.
DR   PDBsum; 3EH9; -.
DR   PDBsum; 3EHA; -.
DR   PDBsum; 3F5G; -.
DR   PDBsum; 3F5U; -.
DR   PDBsum; 3GU4; -.
DR   PDBsum; 3GU5; -.
DR   PDBsum; 3GU6; -.
DR   PDBsum; 3GU7; -.
DR   PDBsum; 3GU8; -.
DR   PDBsum; 3GUB; -.
DR   ProteinModelPortal; P53355; -.
DR   SMR; P53355; 4-315, 347-629, 348-664, 984-1296, 1301-1393.
DR   IntAct; P53355; 10.
DR   MINT; MINT-1136108; -.
DR   STRING; P53355; -.
DR   PhosphoSite; P53355; -.
DR   Ensembl; ENST00000358077; ENSP00000350785; ENSG00000196730.
DR   Ensembl; ENST00000408954; ENSP00000386135; ENSG00000196730.
DR   Ensembl; ENST00000469640; ENSP00000418885; ENSG00000196730.
DR   Ensembl; ENST00000472284; ENSP00000417076; ENSG00000196730.
DR   GeneID; 1612; -.
DR   KEGG; hsa:1612; -.
DR   CTD; 1612; -.
DR   GeneCards; GC09P090112; -.
DR   HGNC; HGNC:2674; DAPK1.
DR   MIM; 600831; gene.
DR   PharmGKB; PA27142; -.
DR   eggNOG; prNOG06302; -.
DR   HOVERGEN; HBG051296; -.
DR   BRENDA; 2.7.11.1; 247.
DR   Pathway_Interaction_DB; ifngpathway; IFN-gamma pathway.
DR   Reactome; REACT_578; Apoptosis.
DR   ArrayExpress; P53355; -.
DR   Bgee; P53355; -.
DR   CleanEx; HS_DAPK1; -.
DR   Genevestigator; P53355; -.
DR   GermOnline; ENSG00000196730; Homo sapiens.
DR   GO; GO:0015629; C:actin cytoskeleton; IDA:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0005524; F:ATP binding; IDA:UniProtKB.
DR   GO; GO:0005516; F:calmodulin binding; IDA:UniProtKB.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IEA:UniProtKB-KW.
DR   GO; GO:0006915; P:apoptosis; IEA:UniProtKB-KW.
DR   GO; GO:0008624; P:induction of apoptosis by extracellular sig...; IMP:UniProtKB.
DR   GO; GO:0007243; P:intracellular protein kinase cascade; IDA:UniProtKB.
DR   GO; GO:0006468; P:protein amino acid phosphorylation; IDA:UniProtKB.
DR   InterPro; IPR002110; Ankyrin_rpt.
DR   InterPro; IPR020683; Ankyrin_rpt-contain_dom.
DR   InterPro; IPR000488; Death.
DR   InterPro; IPR011029; DEATH-like.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_cat_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR017442; Se/Thr_prot_kinase-like_dom.
DR   InterPro; IPR008271; Ser/Thr_prot_kinase_AS.
DR   InterPro; IPR002290; Ser/Thr_prot_kinase_dom.
DR   Gene3D; G3DSA:1.25.40.20; ANK; 3.
DR   Gene3D; G3DSA:1.10.533.10; DEATH_like; 1.
DR   Pfam; PF00023; Ank; 6.
DR   Pfam; PF00531; Death; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00248; ANK; 9.
DR   SMART; SM00005; DEATH; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF48403; ANK; 1.
DR   SUPFAM; SSF47986; DEATH_like; 1.
DR   SUPFAM; SSF56112; Kinase_like; 1.
DR   PROSITE; PS50297; ANK_REP_REGION; 1.
DR   PROSITE; PS50088; ANK_REPEAT; 7.
DR   PROSITE; PS50017; DEATH_DOMAIN; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; ANK repeat; Apoptosis;
KW   ATP-binding; Calmodulin-binding; Complete proteome; Cytoplasm; Kinase;
KW   Nucleotide-binding; Phosphoprotein; Polymorphism; Repeat;
KW   Serine/threonine-protein kinase; Transferase; Ubl conjugation.
FT   CHAIN         1   1430       Death-associated protein kinase 1.
FT                                /FTId=PRO_0000085910.
FT   DOMAIN       13    275       Protein kinase.
FT   REPEAT      378    407       ANK 1.
FT   REPEAT      411    440       ANK 2.
FT   REPEAT      444    473       ANK 3.
FT   REPEAT      477    506       ANK 4.
FT   REPEAT      510    539       ANK 5.
FT   REPEAT      543    572       ANK 6.
FT   REPEAT      576    605       ANK 7.
FT   REPEAT      609    638       ANK 8.
FT   REPEAT      875    904       ANK 9.
FT   REPEAT     1162   1196       ANK 10.
FT   DOMAIN     1312   1396       Death.
FT   NP_BIND      19     27       ATP.
FT   NP_BIND      94     96       ATP.
FT   REGION      267    334       Calmodulin-binding.
FT   ACT_SITE    139    139       Proton acceptor (By similarity).
FT   BINDING      42     42       ATP.
FT   BINDING     100    100       ATP.
FT   BINDING     161    161       ATP.
FT   MOD_RES     308    308       Phosphoserine; by autocatalysis.
FT   VAR_SEQ     477    498       EEETPLHCAAWHGYYSVAKALC -> GRRNPPALCCLARLL
FT                                LCGQSPL (in isoform 2).
FT                                /FTId=VSP_035459.
FT   VAR_SEQ     499   1430       Missing (in isoform 2).
FT                                /FTId=VSP_035460.
FT   VARIANT     416    416       V -> I (in dbSNP:rs12343465).
FT                                /FTId=VAR_033235.
FT   VARIANT     461    461       A -> S.
FT                                /FTId=VAR_040420.
FT   VARIANT     519    519       S -> A.
FT                                /FTId=VAR_040421.
FT   VARIANT     540    540       C -> Y (in dbSNP:rs56327474).
FT                                /FTId=VAR_040422.
FT   VARIANT     591    591       P -> L.
FT                                /FTId=VAR_060693.
FT   VARIANT     622    622       I -> M.
FT                                /FTId=VAR_060694.
FT   VARIANT     941    941       M -> T.
FT                                /FTId=VAR_040423.
FT   VARIANT     977    977       R -> W.
FT                                /FTId=VAR_040424.
FT   VARIANT     978    978       K -> N.
FT                                /FTId=VAR_040425.
FT   VARIANT     993    993       Y -> C.
FT                                /FTId=VAR_040426.
FT   VARIANT     994    994       D -> E.
FT                                /FTId=VAR_040427.
FT   VARIANT    1005   1005       E -> Q.
FT                                /FTId=VAR_040428.
FT   VARIANT    1007   1007       D -> Y.
FT                                /FTId=VAR_040429.
FT   VARIANT    1008   1008       L -> P.
FT                                /FTId=VAR_040430.
FT   VARIANT    1010   1010       R -> C.
FT                                /FTId=VAR_040431.
FT   VARIANT    1018   1018       T -> A.
FT                                /FTId=VAR_040432.
FT   VARIANT    1272   1272       M -> I (in dbSNP:rs56169226).
FT                                /FTId=VAR_040433.
FT   VARIANT    1344   1344       N -> S (in dbSNP:rs1056719).
FT                                /FTId=VAR_033236.
FT   VARIANT    1346   1346       N -> S (in dbSNP:rs1056719).
FT                                /FTId=VAR_040434.
FT   VARIANT    1405   1405       G -> V (in dbSNP:rs36220450).
FT                                /FTId=VAR_040435.
FT   MUTAGEN      42     42       K->A: Loss of activity, apoptotic
FT                                function and of autophosphorylation.
FT   MUTAGEN     308    308       S->A: Elevated Ca(2+)-calmodulin binding
FT                                and Ca(2+)-calmodulin-independent kinase
FT                                activity. Increases apoptotic activity.
FT   MUTAGEN     308    308       S->D: Reduced Ca(2+)-calmodulin binding
FT                                and Ca(2+)-calmodulin-independent kinase
FT                                activity. Decreases apoptotic activity.
FT   MUTAGEN     313    313       S->A: Minimal effect on activity.
FT   CONFLICT   1217   1217       S -> G (in Ref. 3; CAH18690).
FT   HELIX         9     11
FT   STRAND       13     21
FT   STRAND       23     32
FT   TURN         33     35
FT   STRAND       38     46
FT   STRAND       48     51
FT   STRAND       53     56
FT   HELIX        58     70
FT   STRAND       79     84
FT   STRAND       86     94
FT   HELIX       101    108
FT   HELIX       113    132
FT   HELIX       142    144
FT   STRAND      145    148
FT   STRAND      150    154
FT   STRAND      157    159
FT   TURN        181    183
FT   HELIX       186    189
FT   HELIX       197    212
FT   HELIX       222    230
FT   HELIX       238    241
FT   HELIX       246    253
FT   TURN        260    262
FT   HELIX       266    271
FT   TURN        273    275
SQ   SEQUENCE   1430 AA;  160073 MW;  5FD8E96E69B74CF7 CRC64;
     MTVFRQENVD DYYDTGEELG SGQFAVVKKC REKSTGLQYA AKFIKKRRTK SSRRGVSRED
     IEREVSILKE IQHPNVITLH EVYENKTDVI LILELVAGGE LFDFLAEKES LTEEEATEFL
     KQILNGVYYL HSLQIAHFDL KPENIMLLDR NVPKPRIKII DFGLAHKIDF GNEFKNIFGT
     PEFVAPEIVN YEPLGLEADM WSIGVITYIL LSGASPFLGD TKQETLANVS AVNYEFEDEY
     FSNTSALAKD FIRRLLVKDP KKRMTIQDSL QHPWIKPKDT QQALSRKASA VNMEKFKKFA
     ARKKWKQSVR LISLCQRLSR SFLSRSNMSV ARSDDTLDEE DSFVMKAIIH AINDDNVPGL
     QHLLGSLSNY DVNQPNKHGT PPLLIAAGCG NIQILQLLIK RGSRIDVQDK GGSNAVYWAA
     RHGHVDTLKF LSENKCPLDV KDKSGEMALH VAARYGHADV AQLLCSFGSN PNIQDKEEET
     PLHCAAWHGY YSVAKALCEA GCNVNIKNRE GETPLLTASA RGYHDIVECL AEHGADLNAC
     DKDGHIALHL AVRRCQMEVI KTLLSQGCFV DYQDRHGNTP LHVACKDGNM PIVVALCEAN
     CNLDISNKYG RTPLHLAANN GILDVVRYLC LMGASVEALT TDGKTAEDLA RSEQHEHVAG
     LLARLRKDTH RGLFIQQLRP TQNLQPRIKL KLFGHSGSGK TTLVESLKCG LLRSFFRRRR
     PRLSSTNSSR FPPSPLASKP TVSVSINNLY PGCENVSVRS RSMMFEPGLT KGMLEVFVAP
     THHPHCSADD QSTKAIDIQN AYLNGVGDFS VWEFSGNPVY FCCYDYFAAN DPTSIHVVVF
     SLEEPYEIQL NQVIFWLSFL KSLVPVEEPI AFGGKLKNPL QVVLVATHAD IMNVPRPAGG
     EFGYDKDTSL LKEIRNRFGN DLHISNKLFV LDAGASGSKD MKVLRNHLQE IRSQIVSVCP
     PMTHLCEKII STLPSWRKLN GPNQLMSLQQ FVYDVQDQLN PLASEEDLRR IAQQLHSTGE
     INIMQSETVQ DVLLLDPRWL CTNVLGKLLS VETPRALHHY RGRYTVEDIQ RLVPDSDVEE
     LLQILDAMDI CARDLSSGTM VDVPALIKTD NLHRSWADEE DEVMVYGGVR IVPVEHLTPF
     PCGIFHKVQV NLCRWIHQQS TEGDADIRLW VNGCKLANRG AELLVLLVNH GQGIEVQVRG
     LETEKIKCCL LLDSVCSTIE NVMATTLPGL LTVKHYLSPQ QLREHHEPVM IYQPRDFFRA
     QTLKETSLTN TMGGYKESFS SIMCFGCHDV YSQASLGMDI HASDLNLLTR RKLSRLLDPP
     DPLGKDWCLL AMNLGLPDLV AKYNTNNGAP KDFLPSPLHA LLREWTTYPE STVGTLMSKL
     RELGRRDAAD FLLKASSVFK INLDGNGQEA YASSCNSGTS YNSISSVVSR
//
